Home > Urology > EAU 2020 > Letter from the Editor

Letter from the Editor

Prof. Hendrik Van Poppel
EAU 2020
Dear Reader, The 35th Annual EAU Congress was held between 17 and 26 July and consisted of the 3-day EAU20 Virtual Congress and 7-day Theme week. This year’s Annual EAU Congress was supposed to be held in Amsterdam. However, due to the COVID-19 pandemic, the congress went virtual for the first time. The congress provided state-of-the-art urological science and education and comprised hot topics, cutting edge science, and important updates in a mix of oncology and non-oncology sessions. New urosepsis data of the prospective observational SERPENS study indicated the use of early selective antibiotic therapy. The phase 3 KEYNOTE-426 trial demonstrated a significant survival advantage for patients with metastatic renal-cell carcinoma receiving pembrolizumab and axitinib with no difference in quality of life compared with sunitinib. A debate was held on upfront cytoreductive nephrectomy in renal cancer surgery, confirming its role in patients that do...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on